| PRD_000785 | Name: | Largazole | Formula: | C21 H29 N4 O4 S3 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002365 | Name: | phazolicin | Formula: | C74 H104 N29 O27 S3 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
| PRD_002369 | Name: | ecumicin | Formula: | C83 H135 N14 O17 | Definition date: | 2020-05-13 | Last modified: | 2023-11-03 |
|
| PRD_002390 | Name: | Papain-like protease peptide inhibitor VIR251 | Formula: | C22 H33 N5 O7 | Definition date: | 2020-05-20 | Last modified: | 2023-11-03 |
|
| PRD_002391 | Name: | covalently bound calpain inhibitor II | Formula: | C19 H37 N3 O4 S | Definition date: | 2020-06-17 | Last modified: | 2023-11-03 |
|
| PRD_002392 | Name: | UAW246 | Formula: | C25 H36 N4 O6 | Definition date: | 2020-06-17 | Last modified: | 2023-11-03 |
|
| PRD_002394 | Name: | UAW248 | Formula: | C30 H45 N5 O7 | Definition date: | 2020-06-17 | Last modified: | 2023-11-03 |
|
| PRD_000814 | Name: | N-{[(3R,4R,7S,10R,11R)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-4-yl]carbonyl}glycine | Formula: | C23 H34 N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000823 | Name: | N-propanoyl-D-alanyl-(4R)-4-[(7-bromoisoquinolin-1-yl)oxy]-N-{(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-L-prolinamide | Formula: | C29 H34 Br N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000842 | Name: | PTA-SFTI INHIBITOR | Formula: | C66 H106 N20 O18 S2 | Description: | Bowman-Birk Inhibitor | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000846 | Name: | TRYPSIN INHIBITOR 1 | Formula: | C66 H106 N20 O18 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_000857 | Name: | SAH-p53-8 stapled-peptide | Formula: | C96 H151 N26 O25 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_002417 | Name: | Ac-VRHA-conh-[4-(4-butyl)-phenoxy-1-phenyl-2-butyl] | Formula: | C43 H66 N10 O7 | Definition date: | 2023-10-25 | Last modified: | 2023-10-25 |
|
| PRD_002443 | Name: | SiaLac-amidine-Lys | Formula: | C33 H57 N5 O20 S | Definition date: | 2023-09-27 | Last modified: | 2023-09-27 |
|
| PRD_002387 | Name: | tert-butyl N-[5-phenyl-3-(2-phenylethylcarbamoyl)thiophen-2-yl]carbamate | Formula: | C24 H26 N2 O3 S | Definition date: | 2023-09-27 | Last modified: | 2023-09-27 |
|
| PRD_000102 | Name: | CYCLIC HEXAPEPTIDE RR(NAL)(NAL)RF | Formula: | C53 H70 N15 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000103 | Name: | CYCLIC HEXAPEPTIDE KKWWKF | Formula: | C49 H68 N11 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000104 | Name: | CYCLIC HEXAPEPTIDE RRYYRF | Formula: | C45 H66 N15 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000105 | Name: | CYCLIC HEXAPEPTIDE CYC-(RRWWRF) | Formula: | C49 H68 N17 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000106 | Name: | BOC-(D-NLE-L-NLE)4-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C79 H146 N12 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000107 | Name: | H-(L-TYR-D-TYR)4-LYS-OH | Formula: | C78 H87 N10 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000108 | Name: | HCO-(D-NLE-L-NLE)3-D-MENLE-L-NLE-D-NLE-L-NLE-OME | Formula: | C63 H116 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000109 | Name: | BOC-L-NLE-(D-NLE-L-NLE)5-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | Formula: | C96 H177 N15 O18 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000110 | Name: | DLY-HGL-AGD-LHC-AGD-LHC-CUD-LYS | Formula: | C60 H81 N34 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000117 | Name: | ARYLOMYCIN A2 | Formula: | C42 H60 N6 O11 | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|